Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, through UBS AG, has acquired a significant stake in Renalytix PLC, now holding 30,579,354 voting rights, representing 6.997265% of the total voting rights. This acquisition crossed a notification threshold on April 14, 2026, and was formally notified to the issuer on April 15, 2026. There are no reported holdings through financial instruments.

Disclaimer*

UK 100

Latest directors dealings